LENSAR Inc (LNSR)
LENSAR Inc operates in the Medical - Devices industry of the Healthcare sector, headquartered in Orlando, FL, US. The stock last traded at $6.92, down 2.19% on the session, giving a market capitalisation of $85.0M. On trailing twelve-month figures it carries a trailing P/E of 5.45, a net margin of 57.6%. Its beta of 0.97 implies it has historically moved less than the broad market.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
LENSAR Inc is most often compared with the following Healthcare names: